Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05280470 |
|---|---|
| Brief Title: | Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01) |
| First Submitted : | February 23, 2022 |
| First Submitted that Met QC Criteria : | March 4, 2022 |
| First Posted : | March 15, 2022 |
| Last Update Submitted that Met QC Criteria : | April 8, 2024 |
| Last Update Posted : | April 9, 2024 |